Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 469 | N/A | N/A | N/A |
| Receivables | 956 | N/A | N/A | N/A |
| Other current assets | 264 | 0 | 0 | 0 |
| TOTAL | $1,984 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,140 | N/A | N/A | N/A |
| Intangibles | 3,361 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,067 | 0 | 0 | 0 |
| TOTAL | $5,567 | $N/A | $N/A | $N/A |
| Total Assets | $7,552 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 3,710 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,083 | 0 | 0 | 0 |
| Accrued Expenses | 1,353 | N/A | N/A | N/A |
| Other current liabilities | 2,948 | N/A | N/A | N/A |
| TOTAL | $9,094 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 1,401 | 0 | 0 | 0 |
| TOTAL | $1,401 | $N/A | $N/A | $N/A |
| Total Liabilities | $10,495 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | N/A | N/A | N/A |
| Retained earnings | -23,278 | N/A | N/A | N/A |
| TOTAL | $-2,943 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $7,552 | $0 | $0 | $0 |